{"id":15959,"date":"2018-09-18T09:35:21","date_gmt":"2018-09-18T09:35:21","guid":{"rendered":"https:\/\/celonpharma.com\/?p=15959"},"modified":"2018-09-18T09:35:21","modified_gmt":"2018-09-18T09:35:21","slug":"celon-pharma-on-esketamine-at-the-3rd-central-european-biomedical-congress-cebc","status":"publish","type":"post","link":"https:\/\/celon.group\/en\/2018\/09\/18\/celon-pharma-on-esketamine-at-the-3rd-central-european-biomedical-congress-cebc\/","title":{"rendered":"Celon Pharma on Esketamine at the 3rd Central European Biomedical Congress (CEBC)"},"content":{"rendered":"<p style=\"text-align: justify;\">Representatives of the Celon Pharma Neuropsychiatry Research Group took part in the 3rd Central European Biomedical Congress (CEBC) which was held on 15-18 September this year.<\/p>\n<p style=\"text-align: justify;\">This is the largest scientific conference dedicated to preclinical research and biomedical sciences in our part of Europe. The theme of this year\u2019s edition was, among others, neuropsychiatry.<\/p>\n<p style=\"text-align: justify;\">During a poster session at the conference, Celon Pharma representatives presented results of preclinical research carried out under the DiSK project &#8211; &#8220;New S-ketamine therapy for treatment-resistant depression\u201d co-financed by the National Centre for Research and Development (NCBR) under the POIR 1\/1.1.1.<\/p>\n<p style=\"text-align: justify;\">The conference is organised by the Institute of Pharmacology of the Polish Academy of Sciences in Cracow, the Jagiellonian University Medical College and the Polish Toxicology Society.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Representatives of the Celon Pharma Neuropsychiatry Research Group took part in the 3rd Central European Biomedical Congress (CEBC) which was held on 15-18 September this year. This is the largest scientific conference dedicated to preclinical research and biomedical sciences in our part of Europe. The theme of this year\u2019s edition was, among others, neuropsychiatry. During<a class=\"excerpt-read-more float-right\" href=\"https:\/\/celon.group\/en\/2018\/09\/18\/celon-pharma-on-esketamine-at-the-3rd-central-european-biomedical-congress-cebc\/\" title=\"ReadCelon Pharma on Esketamine at the 3rd Central European Biomedical Congress (CEBC)\">Read more &raquo;<\/a><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[26],"tags":[],"class_list":["post-15959","post","type-post","status-publish","format-standard","hentry","category-general-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.8.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Celon Pharma on Esketamine at the 3rd Central European Biomedical Congress (CEBC) - CelonGROUP<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/celon.group\/en\/2018\/09\/18\/celon-pharma-on-esketamine-at-the-3rd-central-european-biomedical-congress-cebc\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Celon Pharma on Esketamine at the 3rd Central European Biomedical Congress (CEBC) - CelonGROUP\" \/>\n<meta property=\"og:description\" content=\"Representatives of the Celon Pharma Neuropsychiatry Research Group took part in the 3rd Central European Biomedical Congress (CEBC) which was held on 15-18 September this year. This is the largest scientific conference dedicated to preclinical research and biomedical sciences in our part of Europe. The theme of this year\u2019s edition was, among others, neuropsychiatry. DuringRead more &raquo;\" \/>\n<meta property=\"og:url\" content=\"http:\/\/celon.group\/en\/2018\/09\/18\/celon-pharma-on-esketamine-at-the-3rd-central-european-biomedical-congress-cebc\/\" \/>\n<meta property=\"og:site_name\" content=\"CelonGROUP\" \/>\n<meta property=\"article:published_time\" content=\"2018-09-18T09:35:21+00:00\" \/>\n<meta name=\"author\" content=\"Ma\u0142gorzata Siewierska\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ma\u0142gorzata Siewierska\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/celon.group\/en\/2018\/09\/18\/celon-pharma-on-esketamine-at-the-3rd-central-european-biomedical-congress-cebc\/\",\"url\":\"http:\/\/celon.group\/en\/2018\/09\/18\/celon-pharma-on-esketamine-at-the-3rd-central-european-biomedical-congress-cebc\/\",\"name\":\"Celon Pharma on Esketamine at the 3rd Central European Biomedical Congress (CEBC) - CelonGROUP\",\"isPartOf\":{\"@id\":\"https:\/\/celon.group\/en\/#website\"},\"datePublished\":\"2018-09-18T09:35:21+00:00\",\"author\":{\"@id\":\"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf\"},\"breadcrumb\":{\"@id\":\"http:\/\/celon.group\/en\/2018\/09\/18\/celon-pharma-on-esketamine-at-the-3rd-central-european-biomedical-congress-cebc\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/celon.group\/en\/2018\/09\/18\/celon-pharma-on-esketamine-at-the-3rd-central-european-biomedical-congress-cebc\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/celon.group\/en\/2018\/09\/18\/celon-pharma-on-esketamine-at-the-3rd-central-european-biomedical-congress-cebc\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/celon.group\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Celon Pharma on Esketamine at the 3rd Central European Biomedical Congress (CEBC)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/celon.group\/en\/#website\",\"url\":\"https:\/\/celon.group\/en\/\",\"name\":\"CelonGROUP\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/celon.group\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf\",\"name\":\"Ma\u0142gorzata Siewierska\",\"url\":\"https:\/\/celon.group\/en\/author\/malgorzata-siewierska\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Celon Pharma on Esketamine at the 3rd Central European Biomedical Congress (CEBC) - CelonGROUP","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/celon.group\/en\/2018\/09\/18\/celon-pharma-on-esketamine-at-the-3rd-central-european-biomedical-congress-cebc\/","og_locale":"en_US","og_type":"article","og_title":"Celon Pharma on Esketamine at the 3rd Central European Biomedical Congress (CEBC) - CelonGROUP","og_description":"Representatives of the Celon Pharma Neuropsychiatry Research Group took part in the 3rd Central European Biomedical Congress (CEBC) which was held on 15-18 September this year. This is the largest scientific conference dedicated to preclinical research and biomedical sciences in our part of Europe. The theme of this year\u2019s edition was, among others, neuropsychiatry. DuringRead more &raquo;","og_url":"http:\/\/celon.group\/en\/2018\/09\/18\/celon-pharma-on-esketamine-at-the-3rd-central-european-biomedical-congress-cebc\/","og_site_name":"CelonGROUP","article_published_time":"2018-09-18T09:35:21+00:00","author":"Ma\u0142gorzata Siewierska","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ma\u0142gorzata Siewierska","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/celon.group\/en\/2018\/09\/18\/celon-pharma-on-esketamine-at-the-3rd-central-european-biomedical-congress-cebc\/","url":"http:\/\/celon.group\/en\/2018\/09\/18\/celon-pharma-on-esketamine-at-the-3rd-central-european-biomedical-congress-cebc\/","name":"Celon Pharma on Esketamine at the 3rd Central European Biomedical Congress (CEBC) - CelonGROUP","isPartOf":{"@id":"https:\/\/celon.group\/en\/#website"},"datePublished":"2018-09-18T09:35:21+00:00","author":{"@id":"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf"},"breadcrumb":{"@id":"http:\/\/celon.group\/en\/2018\/09\/18\/celon-pharma-on-esketamine-at-the-3rd-central-european-biomedical-congress-cebc\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/celon.group\/en\/2018\/09\/18\/celon-pharma-on-esketamine-at-the-3rd-central-european-biomedical-congress-cebc\/"]}]},{"@type":"BreadcrumbList","@id":"http:\/\/celon.group\/en\/2018\/09\/18\/celon-pharma-on-esketamine-at-the-3rd-central-european-biomedical-congress-cebc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/celon.group\/en\/"},{"@type":"ListItem","position":2,"name":"Celon Pharma on Esketamine at the 3rd Central European Biomedical Congress (CEBC)"}]},{"@type":"WebSite","@id":"https:\/\/celon.group\/en\/#website","url":"https:\/\/celon.group\/en\/","name":"CelonGROUP","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/celon.group\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf","name":"Ma\u0142gorzata Siewierska","url":"https:\/\/celon.group\/en\/author\/malgorzata-siewierska\/"}]}},"_links":{"self":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts\/15959","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/comments?post=15959"}],"version-history":[{"count":0,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts\/15959\/revisions"}],"wp:attachment":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/media?parent=15959"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/categories?post=15959"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/tags?post=15959"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}